Search For "drugs controller"
Pfizer in 'final stages' of getting approval for COVID-19 vaccine in India
Updated : 4 years, 9 months ago IST
New Delhi [India], June 22 (ANI): US pharmaceutical giant Pfizer on Tuesday said it is in the "final stages" of getting approval for its COVID-19 vaccine in India.
Read More
DCGI likely to approve phase 3 trial data of Covaxin on Tuesday
Updated : 4 years, 9 months ago IST
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
Read More
Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt
Updated : 4 years, 9 months ago IST
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
Read More
Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 yea
Read More
DCGI waiver likely to bring foreign vaccines like Pfizer, Moderna a step c
Updated : 4 years, 9 months ago IST
New Delhi [India], June 2 (ANI): The Drugs Controller General of India (DCGI) has done away with specific trials of COVID-19 vaccines that have been approved by other international regulatory bodies - a big move likely to clear the way for foreign vaccines like Pfizer and Moderna for the
Read More
Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibo
Updated : 4 years, 10 months ago IST
New Delhi [India], May 27 (ANI): Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection, the pharmaceutical manufacturer informed on Thursday.
Read More
Karnataka: BJP youth wing demands action against Congress youth wing for i
Updated : 4 years, 10 months ago IST
Bengaluru (Karnataka) [India], May 18 (ANI): BJP youth wing in Bengaluru in a letter to state drugs controller demanded action against Congress youth wing Karnataka president MS Raksha Ramaiah and other workers alleging that they are issuing medicine kits containing drugs that can be sold
Read More
DCGI approves Phase 2, 3 clinical trials of COVAXIN on children aged 2 to
Updated : 4 years, 10 months ago IST
New Delhi [India], May 13 (ANI): The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare.
Read More
DRDO's anti-COVID 2-DG drug effective against different variants: DRDO sci
Updated : 4 years, 10 months ago IST
New Delhi [India], May 8 (ANI): The Defence Research and Development Organisation (DRDO)'s new anti-COVID drug, just approved by the Drugs Controller General of India (DCGI) is effective against different variants of the coronavirus and helps in bringing patients out of oxygen support, sa
Read More
DCGI nods anti-COVID drug developed by DRDO for emergency use
Updated : 4 years, 10 months ago IST
New Delhi [India], May 8 (ANI): The Drugs Controller General of India (DCGI) has approved the emergency use of an anti-COVID drug - 2-deoxy-D-glucose (2-DG) - as an adjunct therapy in moderate to severe COVID-19 cases.
Read More
VINS Bioproducts gets DCGI nod to commence clinical trials for VINCOV-19
Updated : 4 years, 11 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): VINS Bioproducts on Monday received approval from the Drugs Controller General of India (DCGI) to commence the clinical trials for VINCOV-19, an antidote, and a cure against COVID-19, the Hyderabad based immunological company said.
Read More
DGCI approves emergency use of Zydus's Virafin in treating moderate COVID-
Updated : 4 years, 11 months ago IST
New Delhi [India], April 23 (ANI): Zydus Cadila received emergency use approval from the Drugs Controller General of India (DGCI) on Friday for the use of 'Virafin', Pegylated Interferon alpha-2b (PegIFN) in treating moderate COVID-19 infection in adults.
Read More